Significance of neutrophil microparticles in ischaemia-reperfusion: Pro-inflammatory effectors of endothelial senescence and vascular dysfunction.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
07 2020
Historique:
received: 07 06 2019
revised: 14 02 2020
accepted: 08 03 2020
pubmed: 11 6 2020
medline: 29 4 2021
entrez: 11 6 2020
Statut: ppublish

Résumé

Endothelial senescence is an emerging cause of vascular dysfunction. Because microparticles are effectors of endothelial inflammation and vascular injury after ischaemia-reperfusion, we examined leucocyte-derived microparticles of spleen origin as possible contributors. Microparticles were generated from primary rat splenocytes by either lipopolysaccharide or phorbol-myristate-acetate/calcium ionophore, under conditions mimicking innate and adaptive immune responses. Incubation of primary porcine coronary endothelial cells with either type of microparticles, but not with those from unstimulated splenocytes, leads to a similar threefold raise in senescence-associated β-galactosidase activity within 48 hours, indicating accelerated senescence, to endothelial oxidative stress, and a fivefold and threefold increase in p21 and p16 senescence markers after 24 hours. After 12-hour incubation, the endothelial-dependent relaxation of coronary artery rings was reduced by 50%, at distinct optimal microparticle concentration. In vitro, microparticles were pro-thrombotic by up-regulating the local angiotensin system, by prompting tissue factor activity and a secondary generation of pro-coagulant endothelial microparticles. They initiated an early pro-inflammatory response by inducing phosphorylation of NF-κB, MAP kinases and Akt after 1 hour, and up-regulated VCAM-1 and ICAM-1 at 24 hours. Accordingly, VCAM-1 and COX-2 were also up-regulated in the coronary artery endothelium and eNOS down-regulated. Lipopolysaccharide specifically favoured the shedding of neutrophil- and monocyte-derived microparticles. A 80% immuno-depletion of neutrophil microparticles reduced endothelial senescence by 55%, indicating a key role. Altogether, data suggest that microparticles from activated splenocytes prompt early pro-inflammatory, pro-coagulant and pro-senescent responses in endothelial cells through redox-sensitive pathways. The control of neutrophil shedding could preserve the endothelium at site of ischaemia-reperfusion-driven inflammation and delay its dysfunction.

Identifiants

pubmed: 32520423
doi: 10.1111/jcmm.15289
pmc: PMC7339165
doi:

Substances chimiques

Angiotensins 0
Lipopolysaccharides 0
NF-kappa B 0
Vascular Cell Adhesion Molecule-1 0
Thromboplastin 9035-58-9
Cyclooxygenase 2 EC 1.14.99.1
Tetradecanoylphorbol Acetate NI40JAQ945

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7266-7281

Informations de copyright

© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Références

J Thromb Haemost. 2009 Apr;7(4):701-9
pubmed: 19192109
Blood. 2008 Sep 15;112(6):2512-9
pubmed: 18594025
Front Immunol. 2019 May 09;10:1037
pubmed: 31143182
Aging Cell. 2015 Feb;14(1):102-11
pubmed: 25407919
Diabetes. 2005 Jun;54(6):1755-62
pubmed: 15919797
J Immunol. 2008 Jan 15;180(2):817-24
pubmed: 18178820
Am J Transl Res. 2016 Feb 15;8(2):765-77
pubmed: 27158368
Crit Care Med. 2011 Jul;39(7):1739-48
pubmed: 21494101
Circulation. 2001 Nov 27;104(22):2649-52
pubmed: 11723013
Nat Protoc. 2009;4(12):1798-806
pubmed: 20010931
Biochem Pharmacol. 2020 Mar;173:113734
pubmed: 31811867
World J Gastroenterol. 2016 Jun 7;22(21):4966-76
pubmed: 27275089
Transplantation. 2011 Aug 15;92(3):351-8
pubmed: 21681142
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2775-80
pubmed: 17038634
Nat Commun. 2020 Jan 10;11(1):214
pubmed: 31924781
Hypertension. 2013 Apr;61(4):e32
pubmed: 23607135
Hypertens Res. 2017 Dec;40(12):966-975
pubmed: 28878301
Lancet. 2002 Dec 21-28;360(9350):2039-45
pubmed: 12504401
Sci Rep. 2017 Jan 03;7:39501
pubmed: 28045034
Trends Immunol. 2019 Jul;40(7):584-597
pubmed: 31153737
Immune Netw. 2018 Dec 07;18(6):e43
pubmed: 30619629
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2554-2563
pubmed: 28108420
Thromb Haemost. 2016 Apr;115(4):781-8
pubmed: 26676803
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
Thromb Haemost. 2017 Jun 28;117(7):1296-1316
pubmed: 28569921
Nat Med. 2015 Dec;21(12):1424-35
pubmed: 26646499
Circulation. 2017 Jan 17;135(3):280-296
pubmed: 27821539
Shock. 2017 Mar;47(3):313-317
pubmed: 27488091
Curr Pharm Des. 2014;20(22):3579-94
pubmed: 24180381
J Clin Invest. 2012 Feb;122(2):558-68
pubmed: 22214850
Sci Rep. 2017 Aug 15;7(1):8277
pubmed: 28811647
J Vis Exp. 2015 Feb 20;(96):e52651
pubmed: 25742309
J Biol Chem. 2002 Jul 12;277(28):25032-9
pubmed: 11978801
J Cell Mol Med. 2009 Mar;13(3):454-71
pubmed: 19379144
Transplantation. 2012 Feb 15;93(3):e10-1
pubmed: 22277958
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):15-26
pubmed: 21160064
Semin Immunopathol. 2012 Jan;34(1):93-106
pubmed: 21845431
N Engl J Med. 2007 Jun 28;356(26):2754-5
pubmed: 17596618
Atherosclerosis. 2016 Feb;245:1-11
pubmed: 26687997
Thromb Haemost. 2014 Jan;111(1):154-64
pubmed: 24108660
Circ Res. 2010 Oct 29;107(9):1047-57
pubmed: 21030722
Sci Rep. 2018 Jul 13;8(1):10647
pubmed: 30006564
Aging (Albany NY). 2015 Jan;7(1):70-81
pubmed: 25635535
Am J Reprod Immunol. 2016 Jul;76(1):29-37
pubmed: 27108773
Fundam Clin Pharmacol. 2011 Dec;25(6):653-60
pubmed: 21105910
Biol Sex Differ. 2015 May 11;6:10
pubmed: 25964851
J Am Heart Assoc. 2012 Jun;1(3):e001842
pubmed: 23130145
Cytokine. 2014 Feb;65(2):126-9
pubmed: 24355430
J Trauma. 2002 Mar;52(3):443-8
pubmed: 11901317
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2594-604
pubmed: 16990554
J Cell Mol Med. 2020 Jul;24(13):7266-7281
pubmed: 32520423
Am J Transplant. 2009 Mar;9(3):550-7
pubmed: 19260834
Basic Res Cardiol. 2016 Nov;111(6):62
pubmed: 27645145
Mol Med. 2014 Jun 09;20:280-9
pubmed: 24918749
J Gerontol A Biol Sci Med Sci. 2016 Dec;71(12):1581-1590
pubmed: 26672612
Thromb Res. 2019 Nov;183:153-158
pubmed: 31678710
Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):580-3
pubmed: 27252239
J Heart Lung Transplant. 2008 Jan;27(1):38-45
pubmed: 18187085
Blood. 2011 Aug 25;118(8):2366-74
pubmed: 21700772
Int J Cardiol. 2018 May 1;258:249-256
pubmed: 29544939
Sci Rep. 2018 Mar 5;8(1):4020
pubmed: 29507382
Cell Mol Neurobiol. 2018 Jan;38(1):195-208
pubmed: 28884416
Circulation. 2004 Apr 6;109(13):1653-9
pubmed: 15023873
Transplant Proc. 2011 Nov;43(9):3241-5
pubmed: 22099767
Sci Transl Med. 2015 Nov 25;7(315):315ra190
pubmed: 26606969
Front Biosci (Landmark Ed). 2011 Jun 01;16:2499-514
pubmed: 21622191
Intensive Care Med. 2013 Oct;39(10):1695-703
pubmed: 23793890

Auteurs

Ali El Habhab (A)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Raed Altamimy (R)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Malak Abbas (M)

UMR CNRS 7213, Laboratory of Biophotonics and Pharmacology, Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.

Mohamad Kassem (M)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Lamia Amoura (L)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Abdul Wahid Qureshi (AW)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Hanine El Itawi (H)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Guillaume Kreutter (G)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.

Sonia Khemais-Benkhiat (S)

UMR CNRS 7213, Laboratory of Biophotonics and Pharmacology, Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.

Fatiha Zobairi (F)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France.

Valérie B Schini-Kerth (VB)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.

Laurence Kessler (L)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Department of Diabetes and Nutrition Endocrinology, University Hospital of Strasbourg, Strasbourg, France.
Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France.

Florence Toti (F)

INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH